{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:55:52Z","timestamp":1790614552518,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T00:00:00Z","timestamp":1324598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00125-011-2416-x","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T14:07:46Z","timestamp":1324562866000},"page":"835-844","source":"Crossref","is-referenced-by-count":13,"title":["Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes"],"prefix":"10.1007","volume":"55","author":[{"given":"L. A.","family":"Maile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Gollahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Byfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Clemmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,23]]},"reference":[{"key":"2416_CR1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM198309013090904","volume":"309","author":"TJ Merimee","year":"1983","unstructured":"Merimee TJ, Zapf J, Froesch ER (1983) Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl Med 309:527\u2013530","journal-title":"N Engl Med"},{"key":"2416_CR2","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI116877","volume":"92","author":"R Meyer-Schwickerath","year":"1993","unstructured":"Meyer-Schwickerath R (1993) Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest 92:2620\u20132625","journal-title":"J Clin Invest"},{"key":"2416_CR3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diacare.23.4.504","volume":"23","author":"MB Grant","year":"2000","unstructured":"Grant MB, Mames RN, Fitzgerald C et al (2000) The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy. Diabetes Care 23:504\u2013509","journal-title":"Diabetes Care"},{"key":"2416_CR4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1172\/JCI19478","volume":"113","author":"J Ruberte","year":"2004","unstructured":"Ruberte J, Ayuso E, Navarro M et al (2004) Increase in ocular levels of IGF-I in transgenic mice lead to diabetes-like eye disease. J Clin Invest 113:1149\u20131157","journal-title":"J Clin Invest"},{"key":"2416_CR5","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1167\/iovs.07-0014","volume":"48","author":"E Miller","year":"2007","unstructured":"Miller E, Capps BE, Sanghani R, Clemmons DR, Maile L (2007) Regulation of IGF-I signaling in retinal endothelial cells by hyperglycemia. Invest Opthalmol Vis Sci 48:3878\u20133887","journal-title":"Invest Opthalmol Vis Sci"},{"key":"2416_CR6","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1210\/en.2006-1440","volume":"148","author":"LA Maile","year":"2007","unstructured":"Maile LA, Capps BE, Ling Y, Xi G, Clemmons DR (2007) Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Endocrinology 148:2435\u20132443","journal-title":"Endocrinology"},{"key":"2416_CR7","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/me.2007-0552","volume":"22","author":"LA Maile","year":"2008","unstructured":"Maile LA, Capps BE, Miller E et al (2008) Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I. Mol Endocrinol 22:1226\u20131237","journal-title":"Mol Endocrinol"},{"key":"2416_CR8","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1091\/mbc.E03-04-0239","volume":"14","author":"LA Maile","year":"2003","unstructured":"Maile LA, Badley-Clarke J, Clemmons DR (2003) The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Mol Biol Cell 14:3519\u20133528","journal-title":"Mol Biol Cell"},{"key":"2416_CR9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nprot.2010.6","volume":"5","author":"I Arnaoutova","year":"2010","unstructured":"Arnaoutova I, Kleinman HK (2010) In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5:628\u2013635","journal-title":"Nat Protoc"},{"key":"2416_CR10","first-page":"789","volume":"42","author":"Q Xu","year":"2001","unstructured":"Xu Q, Qaum T, Adamis AP (2001) Sensitive blood\u2013retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 42:789\u2013794","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2416_CR11","first-page":"2063","volume":"36","author":"JS Penn","year":"1995","unstructured":"Penn JS, Henry MM, Wall PT, Tolman BL (1995) The range of PaO2 variation determines the severity of oxygen induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci 36:2063\u20132070","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2416_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0029(19970101)36:1<1::AID-JEMT1>3.0.CO;2-V","volume":"36","author":"T Chan-Ling","year":"1997","unstructured":"Chan-Ling T (1997) Glial, vascular and neuronal cytogenesis in whole-mounted cat retina. Microsc Res Tech 36:1\u201316","journal-title":"Microsc Res Tech"},{"key":"2416_CR13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.exer.2009.06.011","volume":"89","author":"SJ Budd","year":"2009","unstructured":"Budd SJ, Thompson H, Hartnett ME (2009) Reduction in endothelial tip cell filopedia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. Exp Eye Res 89:718\u2013727","journal-title":"Exp Eye Res"},{"key":"2416_CR14","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1167\/iovs.06-0450","volume":"47","author":"ME Hartnett","year":"2006","unstructured":"Hartnett ME, Mariniuk DJ, Saito Y, Geisen P, Peterson LJ, McColm JR (2006) Triamcinolone reduces neovascularization, capillary density and IGF-I receptor phosphorylation in a model of oxygen-induced retinopathy. Invest Opthalmol Vis Sci 47:4975\u20134982","journal-title":"Invest Opthalmol Vis Sci"},{"key":"2416_CR15","first-page":"345","volume":"14","author":"P Geisen","year":"2009","unstructured":"Geisen P, Peterson LJ, Martiniuk D, Uppal A, Saito Y, Hartnett ME (2009) Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. Mol Vis 14:345\u2013357","journal-title":"Mol Vis"},{"key":"2416_CR16","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1167\/iovs.05-1343","volume":"47","author":"XQ Werdich","year":"2006","unstructured":"Werdich XQ, Penn JS (2006) Specific involvement of Src family kinase activation in the pathogenesis of retinal neovascularization. Invest Opthalmol Vis Sci 47:5047\u20135056","journal-title":"Invest Opthalmol Vis Sci"},{"key":"2416_CR17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/diabetes.46.10.1619","volume":"46","author":"RS Punglia","year":"1997","unstructured":"Punglia RS, Lu M, Hsu J et al (1997) Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I. Diabetes 46:1619\u20131626","journal-title":"Diabetes"},{"key":"2416_CR18","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/70963","volume":"5","author":"LE Smith","year":"1999","unstructured":"Smith LE, Shen W, Peruzzi C et al (1999) Regulation of vascular endothelial growth factor-dependent neovascularization by insulin-like growth factor-1 receptor. Nat Med 5:1390\u20131395","journal-title":"Nat Med"},{"key":"2416_CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1076\/ceyr.28.4.251.27834","volume":"28","author":"X Xu","year":"2004","unstructured":"Xu X, Zhu Q, Xia S, Zhang S, Gu Q, Luo D (2004) Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozocin-induced diabetic rats. Curr Eye Res 28:251\u2013256","journal-title":"Curr Eye Res"},{"key":"2416_CR20","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1167\/iovs.03-1381","volume":"45","author":"BA Berkowitz","year":"2004","unstructured":"Berkowitz BA, Roberts R, Luan H, Peysakhov J, Mao X, Thomas KA (2004) Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats. Invest Opthalmol Vis Sci 45:2391\u20132398","journal-title":"Invest Opthalmol Vis Sci"},{"key":"2416_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1096-6374(98)80102-0","volume":"8","author":"P Spoerri","year":"1998","unstructured":"Spoerri P, Ellis E, Tarnuzzer R, Grant M (1998) Insulin-like growth factor: receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin. Growth Horm IGF Res 8:125\u2013132","journal-title":"Growth Horm IGF Res"},{"key":"2416_CR22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00417-002-0441-7","volume":"240","author":"CW Spraul","year":"2002","unstructured":"Spraul CW, Baldysiak-Figiel A, Lang GK, Lang GE (2002) Octreotide inhibits growth factor-induced bovine choriocapillary endothelial cells in vitro. Graefes Arch Clin Exp Ophthalmol 240:227\u2013231","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2416_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-120-1-199401010-00009","volume":"120","author":"JW Kolaczynski","year":"1994","unstructured":"Kolaczynski JW, Caro JF (1994) Insulin-like growth factor-I therapy in diabetes: physiologic basis, clinical benefits and risks. Ann Intern Med 120:47\u201355","journal-title":"Ann Intern Med"},{"key":"2416_CR24","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1210\/me.2004-0239","volume":"19","author":"C Treins","year":"2005","unstructured":"Treins C, Giorgett-Peraldi S, Murdaca J, Monthouel-Kartmann MN, van Obberghen E (2005) Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. Mol Endocrinol 19:1304\u20131317","journal-title":"Mol Endocrinol"},{"key":"2416_CR25","first-page":"1695.e1-15","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pearlman J, Piermici DJ et al (2006) Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Opthal 113:1695.e1-15","journal-title":"Opthal"},{"key":"2416_CR26","first-page":"75","volume":"19","author":"J Ideno","year":"2007","unstructured":"Ideno J, Mizukami H, Kakehashi A et al (2007) Prevention of diabetic retinopathy by intraocular soluble ft1 gene transfer in a spontaneously diabetic rat model. Int J Mol Med 19:75\u201379","journal-title":"Int J Mol Med"},{"key":"2416_CR27","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1167\/iovs.08-3328","volume":"50","author":"C Bucolo","year":"2009","unstructured":"Bucolo C, Ward KW, Mazzon E, Cuzzocrea S, Drago F (2009) Protective effects of a coumarin derivative in diabetic rats. Invest Opthalmol Vis Sci 50:3846\u20133852","journal-title":"Invest Opthalmol Vis Sci"},{"key":"2416_CR28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tcb.2009.12.002","volume":"3","author":"E Steed","year":"2010","unstructured":"Steed E, Balda M, Matter K (2010) Dynamics and functions of tight junctions. Trends Cell Biol 3:142\u2013149","journal-title":"Trends Cell Biol"},{"key":"2416_CR29","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2337\/db09-1421","volume":"59","author":"EC Leal","year":"2010","unstructured":"Leal EC, Martins J, Voabil P et al (2010) Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes 59:2637\u20132645","journal-title":"Diabetes"},{"key":"2416_CR30","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1242\/jcs.017897","volume":"121","author":"E Dejana","year":"2008","unstructured":"Dejana E, Orsenigo F, Lampugnani M (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115\u20132122","journal-title":"J Cell Sci"},{"key":"2416_CR31","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1074\/jbc.M804783200","volume":"284","author":"BC Elias","year":"2009","unstructured":"Elias BC, Suzuki T, Seth A et al (2009) Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J Biol Chem 284:1559\u20131569","journal-title":"J Biol Chem"},{"key":"2416_CR32","doi-asserted-by":"crossref","first-page":"21036","DOI":"10.1074\/jbc.M109.016766","volume":"284","author":"T Murakami","year":"2009","unstructured":"Murakami T, Felinski EA, Antonetti DA (2009) Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem 284:21036\u201321046","journal-title":"J Biol Chem"},{"key":"2416_CR33","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1007\/s00018-010-0411-x","volume":"67","author":"X Shen","year":"2010","unstructured":"Shen X, Xi G, Radhakrishnan Clemmons DR (2010) Recruitment of Pyk2 to SHPS-1 signaling complex is required for IGF-I-dependent mitogenic signaling in vascular smooth muscle cells. Cell Mol Life Sci 67:3893\u20133903","journal-title":"Cell Mol Life Sci"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2416-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-011-2416-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2416-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:49:36Z","timestamp":1558597776000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-011-2416-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,23]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1007\/s00125-011-2416-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,23]]}}}